PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.51−0.24 (-13.71%)
Close on Nov 17, 2026Market cap $12.07MP/E –Yield –
PAVmed profit margin
Profit margin (net margin) is net income as a percentage of revenue.
PAVmed's profit margin for the twelve months ending Jun 30, 2026 was -10794.6%. For fiscal 2025 it was 564.8%, against 1328.6% the year before. The highest annual figure on record is 1328.6% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 564.8% | −763.8 |
| FY2024 | Dec 31, 2024 | 1328.6% | +3945.8 |
| FY2023 | Dec 31, 2023 | -2617.3% | +20985.7 |
| FY2022 | Dec 31, 2022 | -23602.9% | −13533.5 |
| FY2021 | Dec 31, 2021 | -10069.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -16315.2% | +182368.2 |
| Q1 FY2026 | Mar 31, 2026 | -272.7% | −237372.7 |
| Q4 FY2025 | Dec 31, 2025 | -2428.8% | −16738.8 |
| Q3 FY2025 | Sep 30, 2025 | -107660.0% | −114125.8 |
| Q2 FY2025 | Jun 30, 2025 | -198683.3% | −197577.4 |
| Q1 FY2025 | Mar 31, 2025 | 237100.0% | +238606.1 |
| Q4 FY2024 | Dec 31, 2024 | 14310.0% | +15648.0 |
| Q3 FY2024 | Sep 30, 2024 | 6465.8% | +8699.8 |
| Q2 FY2024 | Jun 30, 2024 | -1105.9% | +7651.3 |
| Q1 FY2024 | Mar 31, 2024 | -1506.1% | +2514.3 |
| Q4 FY2023 | Dec 31, 2023 | -1338.0% | +16929.8 |
| Q3 FY2023 | Sep 30, 2023 | -2234.0% | +32142.3 |
| Q2 FY2023 | Jun 30, 2023 | -8757.2% | +169.8 |
| Q1 FY2023 | Mar 31, 2023 | -4020.4% | +1718.9 |
| Q4 FY2022 | Dec 31, 2022 | -18267.9% | −12154.4 |
| Q3 FY2022 | Sep 30, 2022 | -34376.3% | – |
| Q1 FY2022 | Mar 31, 2022 | -8927.0% | – |
| Q4 FY2021 | Dec 31, 2021 | -5739.3% | – |
| Q3 FY2021 | Sep 30, 2021 | -6113.5% | – |
See a number that looks wrong?